Top Stories

Featured Pharma News from PHARMABOX.IN

Pfizer sidelines US government in COVID-19 vaccine distribution strategy

Pfizer had already made it quite clear that it doesn’t need the U.S. government to help distribute its COVID-19 vaccine, should it be authorized by the FDA. Now it’s putting an exclamation point on that declaration. The company will not use the government’s chosen distribution partner, McKesson, but rather its own system to deliver the […]

Pfizer sidelines US government in COVID-19 vaccine distribution strategy Read More »

Oxford COVID-19 vaccine trial results due this year, trial chief says

LONDON: The University of Oxford hopes to present late-stage trial results on its COVID-19 vaccine candidate this year though its top scientific investigator cautioned it would still take some time for life to return to normal. A vaccine that works is seen as a game-changer in the battle against the coronavirus, which has killed more

Oxford COVID-19 vaccine trial results due this year, trial chief says Read More »

India is witnessing ‘community transmission’, admits Health Minister Harsh Vardhan – ET HealthWorld

After months of denial, Union Health Minister Harsh Vardhan on Sunday admitted that India is witnessing “community transmission”. “It is limited only to certain districts and states,” he said, in the backdrop of West Bengal’s Chief Minister Mamata Banerjee’s admission on Monday that the community transmission of Covid-19 has started in the state. The health

India is witnessing ‘community transmission’, admits Health Minister Harsh Vardhan – ET HealthWorld Read More »

WHO: Study finds 4 drugs have little to no effect on COVID – ET HealthWorld

The U.N. health agency says the world’s largest randomized trial of COVID-19 treatments found “conclusive evidence” that remdesivir, a drug used to treat U.S. President Donald Trump when he fell ill, has little or no effect on severe cases. The World Health Organization announced Friday the long-awaited results of its six-month “Solidarity Therapeutics Trial” that

WHO: Study finds 4 drugs have little to no effect on COVID – ET HealthWorld Read More »

Pfizer CEO, facing pushback, shifts COVID vaccine timeline to late November

For months, Pfizer CEO Albert Bourla had maintained that the company would know this month whether its BioNTech-shared COVID-19 vaccine works. But top scientists pushed back, the FDA released detailed guidelines and critics grew increasingly louder. Now, finding himself alone in the biopharma world with that bullish estimate, the Big Pharma chief is changing his

Pfizer CEO, facing pushback, shifts COVID vaccine timeline to late November Read More »

Scroll to Top